Theradaptive Secures FDA Approval to Advance OASIS Trial to Pivotal Study Evaluating OsteoAdapt® SP in Spinal Fusion

B FDA authorization marks critical milestone enabling advancement of next-generation bone regeneration therapy for patients with degenerative spinal diseases FREDERICK, Md., April 30, 2026 /PRNewswire/…
posteditor
posteditor
Articles: 17424

Other News